Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Additional Paid-in Capital	Common Stock and Additional Paid-in Capital 1.75% senior convertible notes	Common Stock and Additional Paid-in Capital 2.0% senior convertible notes due 2020	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2018		164.0
Balance at beginning of period at Dec. 31, 2018		$ 421			$ (2,765)	$ 1,051	$ 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings						151	1
Other comprehensive income (loss)					41
Issuance of common stock and stock options exercised (in shares)		1.2
Issuance of common stock and stock options exercised		$ 45
Share repurchase program (in shares)		(1.2)
Share repurchase program						(145)
Share-based compensation expenses		$ 27
Issuance of common stock for acquisition (in shares)		1.4
Issuance of common stock for acquisition		$ 160
Dividends declared						(94)
Balance at ending of period (in shares) at Mar. 30, 2019		165.4
Balance at end of period at Mar. 30, 2019		$ 653			(2,724)	963	18
Balance at beginning of period (in shares) at Dec. 31, 2018		164.0
Balance at beginning of period at Dec. 31, 2018		$ 421			(2,765)	1,051	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 628
Other comprehensive income (loss)	6
Dividends paid to non-controlling interest on subsidiary common stock	3
Balance at ending of period (in shares) at Sep. 28, 2019		171.6
Balance at end of period at Sep. 28, 2019		$ 438			(2,759)	1,220	17
Balance at beginning of period (in shares) at Mar. 30, 2019		165.4
Balance at beginning of period at Mar. 30, 2019		$ 653			(2,724)	963	18
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings						207	1
Other comprehensive income (loss)					(13)
Issuance of common stock and stock options exercised (in shares)		0.5
Issuance of common stock and stock options exercised		$ 33
Share repurchase program (in shares)		(0.2)
Share repurchase program						(25)
Share-based compensation expenses		$ 30
Dividends declared						(94)
Dividends paid to non-controlling interest on subsidiary common stock							(3)
Balance at ending of period (in shares) at Jun. 29, 2019		165.7
Balance at end of period at Jun. 29, 2019		$ 716			(2,737)	1,051	16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	268					267	1
Other comprehensive income (loss)	(22)				(22)
Issuance of common stock and stock options exercised (in shares)		0.4
Issuance of common stock and stock options exercised		$ 12
Issuance of common stock for 2.00% senior convertible notes (in shares)		5.5
Issuance of common stock for 2.00% senior convertible notes		$ 988
Share-based compensation expenses		$ 30
Dividends declared						(98)
Equity component and repurchase of senior convertible notes			$ (10)	$ (1,318)
Balance at ending of period (in shares) at Sep. 28, 2019		171.6
Balance at end of period at Sep. 28, 2019		$ 438			(2,759)	1,220	17
Balance at beginning of period (in shares) at Dec. 31, 2019		171.0
Balance at beginning of period at Dec. 31, 2019	(683)	$ 501			(2,440)	1,239	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings						197	1
Other comprehensive income (loss)					(126)
Issuance of common stock and stock options exercised (in shares)		1.3
Issuance of common stock and stock options exercised		$ 5
Share repurchase program (in shares)		(1.6)
Share repurchase program						(253)
Share-based compensation expenses		$ 38
Dividends declared						(109)
Balance at ending of period (in shares) at Mar. 28, 2020		170.7
Balance at end of period at Mar. 28, 2020		$ 544			(2,566)	1,074	18
Balance at beginning of period (in shares) at Dec. 31, 2019		171.0
Balance at beginning of period at Dec. 31, 2019	(683)	$ 501			(2,440)	1,239	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	540
Other comprehensive income (loss)	$ 7
Share repurchase program (in shares)	(2.9)
Dividends paid to non-controlling interest on subsidiary common stock	$ 4
Balance at ending of period (in shares) at Sep. 26, 2020		170.4
Balance at end of period at Sep. 26, 2020	(740)	$ 669			(2,433)	1,008	16
Balance at beginning of period (in shares) at Mar. 28, 2020		170.7
Balance at beginning of period at Mar. 28, 2020		$ 544			(2,566)	1,074	18
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings						135	1
Other comprehensive income (loss)					91
Issuance of common stock and stock options exercised (in shares)		0.6
Issuance of common stock and stock options exercised		$ 53
Share repurchase program (in shares)		(0.6)
Share repurchase program						(83)
Share-based compensation expenses		$ 31
Dividends declared						(109)
Dividends paid to non-controlling interest on subsidiary common stock							(4)
Balance at ending of period (in shares) at Jun. 27, 2020		170.7
Balance at end of period at Jun. 27, 2020		$ 628			(2,475)	1,017	15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	206					205	1
Other comprehensive income (loss)	$ 42				42
Issuance of common stock and stock options exercised (in shares)		0.4
Issuance of common stock and stock options exercised		$ 10
Share repurchase program (in shares)	(0.7)	(0.7)
Share repurchase program						(105)
Share-based compensation expenses		$ 31
Dividends declared						(109)
Balance at ending of period (in shares) at Sep. 26, 2020		170.4
Balance at end of period at Sep. 26, 2020	$ (740)	$ 669			$ (2,433)	$ 1,008	$ 16